ULIHF (United Laboratories International Holdings) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ULIHF United Laboratories International Holdings Ltd ULIHF
80 GF Score
Price $1.24
GF Value $1.43
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is United Laboratories International Holdings FFO?

FFO (Funds from operations) only applies to REITs.

ULIHF
80GF Score
United Laboratories International Holdings Ltd ULIHF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is United Laboratories International Holdings (ULIHF) Overvalued in 2026?

Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be undervalued. The current stock price of $1.24 is trading 13.3% below its estimated GF Value™ of $1.43. GuruFocus considers United Laboratories International Holdings to be Modestly Undervalued.

Key valuation signals for ULIHF:

  • FFO:
  • GF Value™: $1.43 vs. price of $1.24 (13.3% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the ULIHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


United Laboratories International Holdings Business Description

Other Exchanges 03933:Hong KongUNJ:Germany
Address No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
80GF Score

Get the complete analysis for ULIHF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.24
Price
$1.43
GF Value